Antidoping/True Ski

Information for the athletes

1. WORLD ANTI-DOPING CODE

The World Anti-Doping Code (Code) is the first document to harmonise regulations regarding Anti-Doping across all sports and countries. The Code provides a framework for Anti-Doping policies, rules, and regulations for sport organizations and public authorities. As part of an extensive and unprecedented consultation process, WADA solicited comments from its stakeholders throughout the Code’s development incorporating their suggestions into the document. The Code is a living document, and WADA ensures it evolves regularly by engaging in extensive consultation and thorough review of the Code and its associated International Standards on a periodic basis. Amendments to the original Code 2003 was amended in 2009, and 2015. The next amendments and new version will be in 2021.

2. WHAT IS DOPING?

Doping is defined as the occurrence of one or more of the following anti-doping rule violations:

1. Presence of Prohibited Substance:

Presence of a prohibited substance or its metabolites or markers in an athlete’s sample

2. Use of Prohibited Substance/Method:

Use or attempted use by an athlete of a prohibited substance or method

3. Refusing Sample Collection:

Refusing, or failing without compelling justification, to submit to sample collection after notification as authorized in applicable anti-doping rules, or otherwise evading sample collection

4. Failure to File Whereabouts & Missed Tests:

Violation of applicable requirements regarding athlete availability for out-of-competition testing, including failure to file required whereabouts information and missed tests (i.e. any combination of three missed tests and/or filing failures within an 18-month period may be deemed a doping violation)

5. Tampering:

Tampering or attempted tampering with any part of the doping control process

6. Possession:

Possession of a prohibited substance and prohibited method

7. Trafficking:

Trafficking or attempted trafficking in any prohibited substance or method

8. Administration:

Administration or attempted administration to an athlete of a prohibited substance and/or method; or assisting, encouraging, aiding, abetting, covering up or any other type of complicity involving an anti-doping rule violation or any attempted anti-doping rule violation.

9. Complicity (assisting, encouraging, aiding, abetting, conspiring, covering up or any other type of intentional complicity involving an anti-doping rule violation)

10. Prohibited association

 

3. WHAT SUBSTANCES AND METHODS ARE BANNED?

The List of Prohibited Substances and Methods (List), updated annually by WADA, is the International Standard defining what is prohibited in- and out-of-competition. The List also indicates whether particular substances are banned in particular sports.

Here Athlete can find the 2019 Prohibited List

https://www.wada-ama.org/en/prohibited-list

What else should athletes know about banned substances and methods?

Athletes should always check with the ISMF to find out what additional substances and methods are prohibited in their sport. Also, athletes should always make their doctor aware that they are bound by the specific rules of their sport. Those who are unsure of what a product contains should not take it until they are sure it is not prohibited. Ignorance is never an excuse.

What should athletes know about using substances?

Extreme caution is recommended regarding supplement use. It is WADA’s position that a good diet is of utmost importance to athletes. The use of dietary supplements by athletes is a concern because, in many countries, the manufacturing and labeling of products may not follow strict rules, which may lead to a supplement containing an undeclared substance that is prohibited under anti-doping regulations. A significant number of positive tests have been attributed to the misuse of supplements, and taking a poorly labeled dietary supplement is not an adequate defense in a doping hearing.

What about medical conditions?

Athletes, like all others, may at times experience a medical condition that requires them to use particular medicines. The substances that an athlete may be required to take to treat a condition could fall under the List. However, by applying and obtaining a therapeutic use exemption (TUE) from the IF or NADO, an athlete may be allowed to take the necessary medicine. Athletes who need to apply for a TUE should request more information about the TUE application process from their IF (for international-level athletes) or NADO (for national-level athletes).

 

4. DOPING CONTROLS

Worldwide doping controls — or athlete testing — are carried out in accordance with the Code and the International Standard for Testing and Investigations (ISTI). Athletes who compete at the international and national level may be tested anytime, anywhere. Specially trained and accredited doping control personnel carry out all tests.

The 11 steps of Doping Control

  1. Athlete Selection
  2. Notification
  3. Reporting to the Doping Control Station
  4. Selection of a Collection Vessel
  5. Provision of Sample
  6. Volume of Urine
  7. Selection of a Sample Collection Kit
  8. Splitting the Sample
  9. Sealing the Samples
  10. Measuring Specific Gravity
  11. Completion of the Doping Control Form

VIDEO: WORLD ANTI-DOPING AGENCY – THE DOPING CONTROL PROCESS FOR ATHLETES

1. ATHLETE SELECTION

Athlete can be selected for doping control at any time and any place.

2. NOTIFICATION

A Doping Control Officer (DCO) or chaperon will notify the Athlete that he has been selected for doping control. The DCO or chaperon will inform the Athlete of his rights and responsibilities. These include the right to have a representative present throughout the process. The Athlete will be asked to sign a form confirming that he has been selected for doping control.

3. REPORTING TO THE DOPING CONTROL STATION

Athlete should report immediately to the doping control station. The DCO or chaperon may allow the Athlete to delay reporting to the station for an activity such as a news conference or to complete a training session. However, once the Athlete has been notified and selected for doping control, the DCO or chaperone will accompany him until the completion of the sample collection process.

4. SELECTION OF A COLLECTION VESSEL

Athlete will be given a choice of individually sealed collection vessels. Athlete may select one. Athlete should verify that the equipment is intact and has not been tampered with. Athlete should, at all times, maintain control of the collection vessel.

5. PROVIDING A SAMPLE

During the sample provision, only the Athlete and the DCO or chaperon of the same gender are permitted in the washroom. The Athlete will be asked to wash hands. The Athlete will then be asked to raise or lower clothing so that the DCO or chaperon has an unobstructed view while the Athlete provides the sample.

6. VOLUME OF URINE

The DCO shall ensure, with the Athlete in full view, that he provided the minimum required volume of 90 mL. If at first the Athlete is unable to provide 90 mL, he will be asked to provide more until that level is met.

7. SELECTION OF SAMPLE COLLECTION KIT

Athlete will be given a choice of individual sealed sample collection kits to choose one. Athlete should verify the equipment is intact and has not been tampered with and open the kit. Confirm the sample code numbers on the bottles, the lids and containers all match.

8. SPLITTING THE SAMPLE

The Athlete will split the sample, pouring at least 30 mL into the B bottle and the remaining urine of 60 ml or more into the A bottle. Athlete will be asked to leave a small amount in the collection vessel. The reason for this is so the DCO can measure its specific gravity. Athlete should pour the urine unless he needs help. In this instance, Athlete will need to provide consent of his representative or the DCO to pour on his behalf.

9. SEALING THE SAMPLES

Next, seal both the A and B bottles. Athlete and the DCO should verify that the bottles are sealed properly.

10. MEASURING SPECIFIC GRAVITY

The DCO is required to measure the sample‚ specific gravity. If it does not meet certain requirements, Athlete will be asked to provide another sample.

11. COMPLETING THE DOPING CONTROL FORM

On this form, Athlete should provide information about any medication, prescription or non-prescription or dietary supplements the Athlete has taken recently. This form is also the place to note any comments Athlete may have regarding any part of the doping control process.

Athlete will be asked for consent that sample could be used anonymously for research once the analysis for doping control purposes is completed. Athlete may say yes or no.

Athlete should be absolutely certain everything is correct, including the sample code number and to be sure, too, that the laboratory copy of the form does not include any information that could identify Athlete.

Athlete will be asked to sign the form.

At the completion of collection, Athlete will receive a copy of the doping control form.

The Laboratory process

Athlete samples are packed for shipping by a secure process.

Athlete samples are sent to a WADA-accredited laboratory. When processing samples, that lab will adhere to the International Standard for Laboratories, ensuring the chain of custody is maintained. A sample is analyzed. B sample is securely stored. It may be used to confirm an Adverse Analytical Finding from the A sample. The lab will report the results of the Athlete’s sample analysis to the responsible Anti-Doping Organization and to WADA.

B Sample process

Laboratories analyse samples solely by code numbers, not by athletes names. A laboratory that has analysed an athlete’s A sample reports the results simultaneously to WADA and to the particular Anti-Doping Organization.

Adverse Analytical finding

If an Athlete’s A sample reports a positive result or in the language of the Code, an Adverse Analytical Finding, the organization responsible for results management will conduct an initial review.

That review is focused on two parts:

  1. Does the Athlete have a Therapeutic Use Exemption for the substance found in the sample?
  2. Was the sample collection and analysis done according to procedures?

Athlete will be notified in writing of the results and rights regarding the analysis B sample.

If an Athlete requests a B sample analysis, or if the Anti-Doping Organization requests a B sample analysis, the Athlete may attend or choose to send a representative on his behalf.

In the meantime, a Provisional Suspension must be imposed when an A sample returns an Adverse Analytical Finding due to a Prohibited Method or for a Prohibited Substance other than a Specified Substance. At the same time, the Code grants the Athlete important hearing rights, should the Athlete choose to exercise them, in connection with the imposition of such a suspension. These opportunities can depend on the timing of an individual case.

If the B sample confirms the analysis of the A sample, the Anti-Doping Organization will proceed with the results management process, including the Athlete’s right to a fair hearing.

If the B sample does not confirm the analysis of the A sample, no further action will be taken and any Provisional Suspension will be lifted.

 

5. ISMF COMPETITIONS

The ISMF abides by the World Anti-Doping (WADA) standard for testing and testing procedures. Athletes participating in ISMF approved competitions, and other competitions run by ISMF member associations, are responsible for complying with the World Anti-Doping Code (“the Code”) and all relevant International Standards. All athletes have a right to enjoy competitions that are properly organised under rules that aim to ensure fairness while preventing doping.

Member Associations are responsible for complying with the Code and the ISMF Anti-Doping Policy and Procedures. Member Associations will make agreements in writing with athletes that confirm the athletes’ support for the Anti-Doping Policy and Procedure and the other ISMF rules and regulations.

All athletes affiliated with a National Federation shall be subject to in-competition testing by the ISMF, the athlete’s national federation, and any other Anti-Doping Organization responsible for testing at a competition or event in which they participate. All athletes affiliated with a national federation shall also be subject to out-of-competition testing at any time or place, with or without advance notice, by the ISMF, WADA, the athlete’s national federation, the national anti-doping organization of any country where the athlete is present.

What is in-competition testing?

ADOs coordinate in-competition testing so that there is only one organization testing at an event. Unless provided otherwise in the rules of the relevant IF or event ruling body, in-competition means the period commencing 12 hours before a competition in which the athlete is scheduled to participate through the end of the competition and the sample collection process related to the competition.

Criteria for the selection of athletes is pre-determined, based on the regulations of the relevant IF or event ruling body. Sample collection takes place in accordance with the IST. Athletes are notified of their selection for testing. Samples are analyzed for “in-competition substances” as outlined in the Prohibited List.

What is out-of-competition testing?

Out-of-competition testing, or any testing done outside of an event, ensures that athletes can be tested at any time and at any place.

 

6. REGISTRED TESTING POOL

In accordance with WADA’s International Standards for Testing & Investigation, the ISMF has created the Registered Testing Pool (RTP). The RTP of highest-priority Athletes established separately at the international level by ISMF and at the national level by NADO, who are subject to focused In-Competition and Out-of-Competition Testing and therefore are required to provide whereabouts information as provided in Article 5.6 of the Code and the International Standard for Testing and Investigations. (WADA International Standard for Testing and Investigations 2015).